title: Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs.
abstract: Similar to patients with Alzheimer's disease (AD), dogs exhibit age-dependent cognitive decline, amyloid-β (Aβ) pathology, and evidence of cholinergic hypofunction. The present study sought to further investigate the role of cholinergic hypofunction in the canine model by examining the effect of the cholinesterase inhibitors phenserine and donepezil on performance of two tasks, a delayed non-matching-to-position task (DNMP) designed to assess working memory, and an oddity discrimination learning task designed to assess complex learning, in aged dogs. Phenserine (0.5 mg/kg; PO) significantly improved performance on the DNMP at the longest delay compared to wash-out and partially attenuated scopolamine-induced deficits (15 μg/kg; SC). Phenserine also improved learning on a difficult version of an oddity discrimination task compared to placebo, but had no effect on an easier version. We also examined the effects of three doses of donepezil (0.75, 1.5, and 6 mg/kg; PO) on performance of the DNMP. Similar to the results with phenserine, 1.5 mg/kg of donepezil improved performance at the longest delay compared to baseline and wash-out, indicative of memory enhancement. These results further extend the findings of cholinergic hypofunction in aged dogs and provide pharmacological validation of the canine model with a cholinesterase inhibitor approved for use in AD. Collectively, these studies support utilizing the aged dog in future screening of therapeutics for AD, as well as for investigating the links among cholinergic function, Aβ pathology, and cognitive decline.
authors: Department of Pharmacology, University of Toronto, Toronto, ON, Canada. josepha@intervivosolutions.com
authors: Joseph A
authors: JA
authors: Araujo
authors: Nigel H
authors: NH
authors: Greig
authors: Donald K
authors: DK
authors: Ingram
authors: Johan
authors: J
authors: Sandin
authors: Christina
authors: C
authors: de Rivera
authors: Norton W
authors: NW
authors: Milgram
references: Ann N Y Acad Sci. 2004 Dec;1035:34-48
references: 15681799
references: J Am Anim Hosp Assoc. 2006 Nov-Dec;42(6):407-13
references: 17088386
references: Science. 1982 Jul 30;217(4558):408-14
references: 7046051
references: Neurobiol Learn Mem. 2006 Sep;86(2):197-204
references: 16616528
references: Behav Pharmacol. 1996 Nov;7(6):513-525
references: 11224448
references: Psychopharmacology (Berl). 2004 Aug;175(1):92-8
references: 15029470
references: Neurobiol Learn Mem. 2007 Sep;88(2):249-59
references: 17587610
references: Neurobiol Aging. 1996 Jul-Aug;17(4):653-9
references: 8832640
references: J Pharmacol Exp Ther. 2006 Aug;318(2):855-62
references: 16690718
references: Life Sci. 1987 Jul 27;41(4):453-61
references: 3600187
references: Curr Alzheimer Res. 2005 Jul;2(3):281-90
references: 15974893
references: J Neural Transm Suppl. 1997;49:93-102
references: 9266418
references: Neurobiol Aging. 2005 Jan;26(1):77-90
references: 15585348
references: Ageing Res Rev. 2006 Aug;5(3):354-69
references: 16949888
references: Acta Neurol Scand Suppl. 2000;176:74-84
references: 11261809
references: J Neurosci. 2004 Sep 22;24(38):8205-13
references: 15385603
references: Brain Res Mol Brain Res. 1997 Jun;46(1-2):161-8
references: 9191090
references: Eur J Clin Invest. 1998 Nov;28(11):944-9
references: 9824440
references: Psychopharmacology (Berl). 2008 Aug;199(3):481-94
references: 17657478
references: Psychopharmacol Bull. 1985;21(3):676-9
references: 3898182
references: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Mar;29(3):489-98
references: 15795058
references: Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):599-610
references: 3541054
references: J Clin Psychiatry. 2003;64 Suppl 9:11-7
references: 12934969
references: J Alzheimers Dis. 2008 Dec;15(4):709-20
references: 19096166
references: Psychopharmacology (Berl). 1998 Feb;135(3):242-55
references: 9498727
references: Int J Neuropsychopharmacol. 2006 Apr;9(2):175-89
references: 15877932
references: Psychopharmacology (Berl). 1997 Jun;131(4):406-10
references: 9226744
references: Eur J Pharmacol. 1996 Apr 29;302(1-3):13-20
references: 8790986
references: Neurobiol Aging. 2002 Sep-Oct;23(5):809-18
references: 12392784
references: Eur J Pharmacol. 2007 Apr 30;561(1-3):85-90
references: 17320856
references: Neurobiol Aging. 1998 Sep-Oct;19(5):479-85
references: 9880050
references: Expert Opin Investig Drugs. 2007 Jul;16(7):1087-97
references: 17594192
references: J Alzheimers Dis. 2010;22(4):1201-8
references: 20930279
references: Life Sci. 2005 Jan 21;76(10):1073-81
references: 15620572
references: J Neural Transm Suppl. 1987;24:175-82
references: 2960781
references: J Alzheimers Dis. 2008 Dec;15(4):507-21
references: 19096153
references: Pharmacoeconomics. 1999 Jul;16(1):99-114
references: 10539126
references: Acta Neurol Scand Suppl. 2000;176:60-7
references: 11273593
references: J Neurol Sci. 1983 May;59(2):277-89
references: 6854353
references: Life Sci. 1994;55(25-26):2037-49
references: 7997063
references: Neuropathol Appl Neurobiol. 1978 Jul-Aug;4(4):273-7
references: 703927
references: Neurobiol Aging. 2008 Jan;29(1):39-50
references: 17092609
references: Behav Neurosci. 1994 Feb;108(1):57-68
references: 8192851
references: Learn Mem. 2001 Nov-Dec;8(6):317-25
references: 11773431
references: Behav Brain Res. 1993 Nov 30;57(2):143-53
references: 8117420
references: Psychopharmacology (Berl). 1985;87(2):247-9
references: 3931154
references: Neuroimage. 2006 Jan 1;29(1):234-44
references: 16275022
references: Pharmacol Biochem Behav. 2011 Apr;98(2):203-9
references: 21238475
references: Neuroreport. 1995 Feb 15;6(3):481-4
references: 7766848
references: Neurobiol Aging. 2002 Sep-Oct;23(5):737-45
references: 12392778
references: Behav Neurosci. 2002 Jun;116(3):443-54
references: 12049325
references: Arch Neurol. 1974 Feb;30(2):113-21
references: 4359364
references: Neurobiol Aging. 1998 Sep-Oct;19(5):415-25
references: 9880044
references: J Alzheimers Dis. 2008 Dec;15(4):685-707
references: 19096165
references: J Neurochem. 2002 Jul;82(2):375-81
references: 12124438
references: Behav Neurosci. 1995 Oct;109(5):851-8
references: 8554710
references: Nature. 2006 Mar 16;440(7082):352-7
references: 16541076
references: Neurobiol Learn Mem. 1996 Jul;66(1):11-23
references: 8661247
references: Neurochem Int. 2008 Nov;53(5):103-11
references: 18602955
references: Arch Gen Psychiatry. 1987 May;44(5):418-26
references: 3579494
references: Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):665-76
references: 3541056
references: J Neurol Sci. 1977 Nov;34(2):247-65
references: 144789
references: Curr Drug Targets CNS Neurol Disord. 2003 Jun;2(3):163-71
references: 12769797
references: Age (Dordr). 2005 Mar;27(1):27-37
references: 23598601
references: Xenobiotica. 1999 Nov;29(11):1059-72
references: 10598742
references: Eur J Pharmacol. 2001 Feb 2;412(3):265-72
references: 11166290
references: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Mar;29(3):411-22
references: 15795050
references: Learn Mem. 1999 Jan-Feb;6(1):54-61
references: 10355524
references: J Geriatr Psychiatry Neurol. 1992 Apr-Jun;5(2):72-7
references: 1317178
references: Learn Mem. 2003 Jan-Feb;10(1):64-73
references: 12551965
references: J Neurochem. 1988 Jun;50(6):1914-23
references: 3373218
references: Synapse. 1997 Aug;26(4):341-50
references: 9215593
references: Curr Alzheimer Res. 2010 Nov;7(7):642-51
references: 20704560
references: J Pharmacol Exp Ther. 2007 Jan;320(1):386-96
references: 17003227
references: Psychopharmacology (Berl). 1993;112(4):415-20
references: 7871051
references: Behav Neurosci. 2003 Aug;117(4):813-24
references: 12931965
references: Neuroreport. 1998 Jan 5;9(1):171-6
references: 9592071
references: Learn Mem. 2003 Mar-Apr;10(2):148-60
references: 12663753
references: Behav Pharmacol. 2007 Sep;18(5-6):347-63
references: 17762506
references: Eur J Neurosci. 2002 Jun;15(11):1827-40
references: 12081663
references: Ann Neurol. 2008 May;63(5):621-31
references: 18300284
references: Neurobiol Aging. 2000 Jan-Feb;21(1):89-96
references: 10794853
references: J Neurosci. 2008 Apr 2;28(14):3555-66
references: 18385314
references: Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7605-10
references: 11404470
references: Lancet. 1976 Dec 25;2(8000):1403
references: 63862
references: Curr Alzheimer Res. 2005 Oct;2(4):483-92
references: 16248851
references: Br Med J. 1978 Nov 25;2(6150):1457-9
references: 719462
references: Neurotherapeutics. 2008 Jul;5(3):433-42
references: 18625455
references: J Mol Neurosci. 2004;24(1):85-91
references: 15314255
references: Rev Neurosci. 2000;11(2-3):75-93
references: 10718147
references: Lancet. 1977 Jan 22;1(8004):189
references: 64712
references: Brain Res. 2003 Jan 17;960(1-2):259-62
references: 12505680
references: Prog Neuropsychopharmacol Biol Psychiatry. 2000 Jul;24(5):675-92
references: 11191708
references: Brain Res. 1985 Jun 10;336(1):19-25
references: 4005573
references: Acta Neuropathol. 2006 Aug;112(2):175-83
references: 16775693
references: Vet Clin North Am Small Anim Pract. 2005 May;35(3):675-98
references: 15833565